(Q27022495)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24374500%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

title

Approved but non-funded vaccines: accessing individual protection (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24374500%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24374500%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Shelly A McNeil

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24374500%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Natasha Sarah Crowcroft

5

object named as

Natasha S Crowcroft

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24374500%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

author name string

Gordean Bjornson

6

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24374500%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Brian J Ward

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24374500%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Scott A Halperin

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24374500%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

language of work or name

1 reference

25 December 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24374500%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24374500%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

volume

32

2 references

PubMed

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24374500%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

issue

7

2 references

PubMed

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24374500%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

page(s)

766-770

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24374500%20AND%20SRC:MED&resulttype=core&format=json

National Immunization Technical Advisory Groups (NITAGs): guidance for their establishment and strengthening

3 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.027

An analytical framework for immunization programs in Canada

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.027

Population access to new vaccines in European countries.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.027

Vaccine economics: what price human life?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.027

The price of prevention: what now for immunisation against meningococcus B?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.027

Varicella immunisation practice: Implications for provision of a recommended, non-funded vaccine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.027

Disparities in varicella vaccine coverage in the absence of public funding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.027

Determinants influencing self-paid vaccination coverage, in 0-5 years old Polish children.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.027

Inactivated poliovirus vaccine: past and present experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.027

STATEMENT ON THE RECOMMENDED USE OF HERPES ZOSTER VACCINE: An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI)*†

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.027

Update on Human Papillomavirus (HPV) Vaccines: An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI) †

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.027

Immunization services offered in Québec (Canada) pharmacies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.027

Pharmacist involvement with immunizations: a decade of professional advancement

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.027

Recommendations for the use of rotavirus vaccines in infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.027

Sources and perceived credibility of vaccine-safety information for parents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.027

National immunization strategy. A model for resolving jurisdictional disputes in public health

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.027

Progress report on the National Immunization Strategy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.027

Early experience with human papillomavirus vaccine introduction in the United States, Canada and Australia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.027

Personalized vaccinology: one size and dose might not fit both sexes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.027

Civil society: A critical new advocate for vaccination in Europe

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.027

The potential cost-effectiveness of vaccination against herpes zoster and post-herpetic neuralgia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.027

Cost effectiveness of herpes zoster vaccine in Canada.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.027

Comparison of prescription drug costs in the United States and the United Kingdom, Part 1: statins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.027

Developing vaccine policy: attributes of "just policy" and a proposed template to guide decision and policy making

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.027

The role of health economic analyses in vaccine decision making

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.027

Funding of drugs: do vaccines warrant a different approach?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.027

Addressing the vaccine confidence gap.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.027

Uptake of varicella vaccine--a cross sectional survey of parental attitudes to nationally recommended but unfunded varicella immunisation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.027